When TIS was induced in breast cancer cells by treatment with the chemotherapeutic agent doxorubicin, these cells significantly increased their secretion of VEGF (vascular endothelial growth factor), promoting the proliferation of surrounding vascular endothelial cells and the formation of new blood vessels [55]. This evidence concerns the gene VEGFA and breast carcinoma.